Literature DB >> 24262327

C-reactive protein predicts hematoma growth in intracerebral hemorrhage.

Mario Di Napoli1, Adrian R Parry-Jones, Craig J Smith, Stephen J Hopkins, Mark Slevin, Luca Masotti, Veronica Campi, Puneetpal Singh, Francesca Papa, Aurel Popa-Wagner, Valerica Tudorica, Daniel Agustin Godoy.   

Abstract

BACKGROUND AND
PURPOSE: Early hematoma growth (EHG) occurs in about one third of patients with spontaneous intracerebral hemorrhage. The main aim of this study was to investigate the potential of plasma C-reactive protein (CRP) for predicting EHG after acute spontaneous intracerebral hemorrhage.
METHODS: Plasma CRP was measured within 6 hours of onset (median, 120 minutes) in 399 patients with primary or vitamin K antagonist-associated spontaneous intracerebral hemorrhage and without recent infection. Computed tomography brain scans were performed at baseline and repeated within 24 hours (median, 22 hours). The primary outcome was EHG, defined as absolute growth>12.5 cm3 or relative growth>33%. Secondary outcomes included early neurological worsening (ENW) using the Glasgow Coma Scale and 30-day mortality. Multivariable regression analyses were used to evaluate associations of CRP concentration and outcomes. Kaplan-Meier analysis was used for survival.
RESULTS: EHG occurred in 25.8%, ENW in 19.3%, and mortality was 31.8% at 30 days. Thirty-day mortality was significantly higher in patients with ENW (hazard ratio, 3.21; 95% confidence interval, 2.00-5.17; P<0.0001) and in patients with EHG (hazard ratio, 2.13; 95% confidence interval, 1.42-3.18; P<0.0001, log-rank test). Median CRP was 12 mg/L (interquartile range, 10-17) in the EHG group and 7 mg/L (interquartile range, 4-12.1) in those without EHG (P<0.0001). In multivariable analyses, plasma CRP>10 mg/L independently predicted EHG (odds ratio, 4.71; 95% confidence interval, 2.75-8.06; P<0.0001) and ENW (odds ratio, 2.70; 95% confidence interval, 1.50-4.84; P=0.0009).
CONCLUSIONS: CRP>10 mg/L is independently predictive of EHG and ENW, both of which are associated with increased mortality. Inflammation may be important in contributing to EHG and warrants further investigation.

Entities:  

Keywords:  C-reactive protein; cerebral hemorrhage; inflammation; prognosis

Mesh:

Substances:

Year:  2013        PMID: 24262327     DOI: 10.1161/STROKEAHA.113.001721

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

Review 1.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

2.  An exploratory study of BDNF and oxidative stress marker alterations in subacute and chronic stroke patients affected by neuropathic pain.

Authors:  Mariacristina Siotto; Irene Aprile; Ilaria Simonelli; Costanza Pazzaglia; Mariacarla Ventriglia; Massimo Santoro; Isabella Imbimbo; Rosanna Squitti; Luca Padua
Journal:  J Neural Transm (Vienna)       Date:  2017-10-30       Impact factor: 3.575

3.  Feasibility of a pilot study on point-of-care biomarkers in spontaneous intracerebral hemorrhage in an emergency setting.

Authors:  Eugenia-Maria Mureşan; Adela Golea; Sorana D Bolboacă; Lăcrămioara Perju-Dumbravă
Journal:  Med Pharm Rep       Date:  2021-07-29

4.  Admission Emergency Department Point-of-care Biomarkers for Prediction of Early Mortality in Spontaneous Intracerebral Hemorrhage.

Authors:  Eugenia-Maria Muresan; Adela Golea; Stefan Cristian Vesa; Iulia Givan; Lacramioara Perju-Dumbrava
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

5.  Lactate Dehydrogenase Predicts Early Hematoma Expansion and Poor Outcomes in Intracerebral Hemorrhage Patients.

Authors:  Heling Chu; Chuyi Huang; Jing Dong; Xiaobo Yang; Jun Xiang; Qiang Dong; Yuping Tang
Journal:  Transl Stroke Res       Date:  2019-01-31       Impact factor: 6.829

6.  Can a novel clinical risk score improve pneumonia prediction in acute stroke care? A UK multicenter cohort study.

Authors:  Craig J Smith; Benjamin D Bray; Alex Hoffman; Andreas Meisel; Peter U Heuschmann; Charles D A Wolfe; Pippa J Tyrrell; Anthony G Rudd
Journal:  J Am Heart Assoc       Date:  2015-01-13       Impact factor: 5.501

7.  Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.

Authors:  Adrian R Parry-Jones; Mario Di Napoli; Joshua N Goldstein; Floris H B M Schreuder; Sami Tetri; Turgut Tatlisumak; Bernard Yan; Koen M van Nieuwenhuizen; Nelly Dequatre-Ponchelle; Matthew Lee-Archer; Solveig Horstmann; Duncan Wilson; Fulvio Pomero; Luca Masotti; Christine Lerpiniere; Daniel Agustin Godoy; Abigail S Cohen; Rik Houben; Rustam Al-Shahi Salman; Paolo Pennati; Luigi Fenoglio; David Werring; Roland Veltkamp; Edith Wood; Helen M Dewey; Charlotte Cordonnier; Catharina J M Klijn; Fabrizio Meligeni; Stephen M Davis; Juha Huhtakangas; Julie Staals; Jonathan Rosand; Atte Meretoja
Journal:  Ann Neurol       Date:  2015-05-14       Impact factor: 10.422

8.  Innate Immune Anti-Inflammatory Response in Human Spontaneous Intracerebral Hemorrhage.

Authors:  Anan Shtaya; Leslie R Bridges; Rebecca Williams; Sarah Trippier; Liqun Zhang; Anthony C Pereira; James A R Nicoll; Delphine Boche; Atticus H Hainsworth
Journal:  Stroke       Date:  2021-07-20       Impact factor: 7.914

9.  Characteristics of ischemic stroke and intracranial hemorrhage in patients with nephrotic syndrome.

Authors:  Wen-Yi Huang; Chun-Wei Chang; Chiung-Mei Chen; Kuan-Hsing Chen; Chien-Hung Chang; Hsiu-Chuan Wu; Kuo-Hsuan Chang
Journal:  BMC Nephrol       Date:  2021-06-05       Impact factor: 2.388

10.  Procalcitonin and mortality in status epilepticus: an observational cohort study.

Authors:  Raoul Sutter; Martina Valença; Sarah Tschudin-Sutter; Stephan Rüegg; Stephan Marsch
Journal:  Crit Care       Date:  2015-10-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.